p53 Modulates the Exonuclease Activity of Werner Syndrome Protein

Robert M. Brosh, Parimal Karmakar, Joshua A. Sommers, Qin Yang, Xin Wei Wang, Elisa A. Spillare, Curtis C. Harris, Vilhelm A. Bohr

Research output: Contribution to journalArticlepeer-review

82 Scopus citations


Werner syndrome (WS) is characterized by the early onset of symptoms of premature aging, cancer, and genomic instability. The molecular basis of the defects is not understood but presumably relates to the DNA helicase and exonuclease activities of the protein encoded by the WRN gene that is mutated in the disease. The attenuation of p53-mediated apoptosis in WS cells and reported physical interaction between WRN and the tumor suppressor p53 suggest that p53 and WRN functionally interact in a pathway necessary for the normal cellular response. In this study, we have demonstrated that p53 inhibits the exonuclease activity of the purified full-length recombinant WRN protein. p53 did not have an effect on a truncated amino-terminal WRN fragment that retains exonuclease activity but lacks the physical interaction domain for p53 located in the carboxyl terminus. Two naturally occurring p53 mutants found in human cancer displayed a reduced ability to inhibit WRN exonuclease activity. In cells arrested in S phase with hydroxyurea, WRN exits the nucleolus and colocalizes with p53 in the nucleoplasm. The regulation of WRN function by p53 is likely to play an important role in the maintenance of genomic integrity and prevention of cancer and other clinical symptoms associated with WS.

Original languageEnglish
Pages (from-to)35093-35102
Number of pages10
JournalJournal of Biological Chemistry
Issue number37
StatePublished - Sep 14 2001


Dive into the research topics of 'p53 Modulates the Exonuclease Activity of Werner Syndrome Protein'. Together they form a unique fingerprint.

Cite this